A Small Study Offers a Clue About Premenstrual Dysphoric Disorder (PMDD)

“It’s just hormones” gets said about premenstrual mood dips like it explains anything, when really it just names a symptom and calls it a day. A small 2025 study in blood cells from women with PMDD offers a clue to one possible mechanism — and it’s more interesting than a shrug.

One hypothesis: it may be the withdrawal, not the drop

One hypothesis is that progesterone itself isn’t the mood culprit, and that a metabolite of progesterone called allopregnanolone matters more. Allopregnanolone acts on GABA receptors — the same calming, anxiety-dampening receptors targeted by anti-anxiety medications. On this hypothesis, as progesterone falls sharply in the days before your period, allopregnanolone falls with it, and the brain’s GABA system has to adjust to less calming input. This is a proposed mechanism for PMDD, not something the study below demonstrated.^[1]

A 2025 study looking at gene expression in 29 women with premenstrual dysphoric disorder (PMDD, a severe form of premenstrual mood disorder) and 27 comparison women measured activity in blood cells, not in the brain. It found altered GABA receptor subunit activity during the symptomatic luteal phase compared to the follicular phase in the PMDD group, a small effect. The authors say it is possible that mood symptoms reflect an inability to adjust to neurosteroid fluctuations. These findings concern PMDD, not typical PMS.^[1]

Why this framing actually helps

It reframes “I feel unreasonable this week” as something with a possible biological basis rather than a character problem. In PMDD, the hypothesis is that individual sensitivity in the GABA system varies, which could help explain why people respond so differently to the same hormone shift; that has not been shown for typical premenstrual mood dips.

What can help day to day

• Tracking your cycle alongside your mood for a couple of months — a clear pattern is useful information for you and for a doctor, even if nothing else changes yet (a symptom diary is also commonly used when PMDD is being evaluated; no source is cited here).
• Prioritizing sleep and steady blood sugar in the luteal phase (the week or two before your period) — a common suggestion, though the study above did not test it.
• Movement, which is often suggested for premenstrual mood symptoms (no source is cited here), even though it won’t erase them.
• Getting evaluated if symptoms are severe enough to disrupt work, relationships, or daily functioning — that’s the line between typical PMS and PMDD, and a doctor can walk you through treatment options for PMDD.

This isn’t a self-diagnosis tool, and it’s not medical advice for treating PMDD — it’s context for a real biological process, so a hard week doesn’t just feel like a personal failing.

If you have thoughts of harming yourself, seek help now (988 in the US).

References

1. Stiernman L, Comasco E, Johansson M, Bixo M. “Transcription of GABA_A receptor subunits in circulating monocytes and association to emotional brain function in premenstrual dysphoric disorder.” Translational Psychiatry. 2025;15(1):255. Finding used: in 29 women with PMDD and 27 controls, GABA-A receptor subunit gene expression measured in blood cells differed between the symptomatic luteal phase and the follicular phase in the PMDD group (small effect); the authors say it is possible that symptoms are mediated by an inability to adjust expression in response to neurosteroid fluctuations. DOI: 10.1038/s41398-025-03465-6. ↑︎

Kurt Greiner

Kurt is a digital strategist and IT professional blending emerging technology with practical application to help businesses and individuals streamline their digital presence. His current work focuses on the intersection of intentional living and technological resilience, exploring how individuals can leverage modern tools to navigate the second half of life with purpose.